Global Glucagon Drug Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Glucagon Drug Consumption 2016-2026

2.1.2 Glucagon Drug Consumption CAGR by Region

2.2 Glucagon Drug Segment by Type

2.2.1 Inject Glucagon

2.2.2 Nasal Glucagon

2.3 Glucagon Drug Sales by Type

2.3.1 Global Glucagon Drug Sales Market Share by Type (2016-2021)

2.3.2 Global Glucagon Drug Revenue and Market Share by Type (2016-2021)

2.3.3 Global Glucagon Drug Sale Price by Type (2016-2021)

2.4 Glucagon Drug Segment by Application

2.4.1 Emergency Kits

2.4.2 General Use

2.4.3 Diagnostic & Motility

2.4.4 Cardiogenic Shock

2.4.5 Others

2.5 Glucagon Drug Sales by Application

2.5.1 Global Glucagon Drug Sale Market Share by Application (2016-2021)

2.5.2 Global Glucagon Drug Revenue and Market Share by Application (2016-2021)

2.5.3 Global Glucagon Drug Sale Price by Application (2016-2021)

3 Global Glucagon Drug by Company

3.1 Global Glucagon Drug Sales Market Share by Company

3.1.1 Global Glucagon Drug Sales by Company (2019-2021)

3.1.2 Global Glucagon Drug Sales Market Share by Company (2019-2021)

3.2 Global Glucagon Drug Revenue Market Share by Company

3.2.1 Global Glucagon Drug Revenue by Company (2019-2021)

3.2.2 Global Glucagon Drug Revenue Market Share by Company (2019-2021)

3.3 Global Glucagon Drug Sale Price by Company

3.4 Global Manufacturers Glucagon Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Glucagon Drug Product Location Distribution

3.4.2 Players Glucagon Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Glucagon Drug by Region

4.1 Global Glucagon Drug by Region

4.1.1 Global Glucagon Drug Sales by Region

4.1.2 Global Glucagon Drug Revenue by Region

4.2 Americas Glucagon Drug Sales Growth

4.3 APAC Glucagon Drug Sales Growth

4.4 Europe Glucagon Drug Sales Growth

4.5 Middle East & Africa Glucagon Drug Sales Growth

5 Americas

5.1 Americas Glucagon Drug Sales by Country

5.1.1 Americas Glucagon Drug Sales by Country (2016-2021)

5.1.2 Americas Glucagon Drug Revenue by Country (2016-2021)

5.2 Americas Glucagon Drug Sales by Type

5.3 Americas Glucagon Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Glucagon Drug Sales by Region

6.1.1 APAC Glucagon Drug Sales by Region (2016-2021)

6.1.2 APAC Glucagon Drug Revenue by Region (2016-2021)

6.2 APAC Glucagon Drug Sales by Type

6.3 APAC Glucagon Drug Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Glucagon Drug by Country

7.1.1 Europe Glucagon Drug Sales by Country (2016-2021)

7.1.2 Europe Glucagon Drug Revenue by Country (2016-2021)

7.2 Europe Glucagon Drug Sales by Type

7.3 Europe Glucagon Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Glucagon Drug by Country

8.1.1 Middle East & Africa Glucagon Drug Sales by Country (2016-2021)

8.1.2 Middle East & Africa Glucagon Drug Revenue by Country (2016-2021)

8.2 Middle East & Africa Glucagon Drug Sales by Type

8.3 Middle East & Africa Glucagon Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Glucagon Drug Distributors

10.3 Glucagon Drug Customer

11 Global Glucagon Drug Market Forecast

11.1 Global Glucagon Drug Forecast by Region

11.1.1 Global Glucagon Drug Forecast by Regions (2021-2026)

11.2.2 Global Glucagon Drug Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Glucagon Drug Forecast by Type

11.7 Global Glucagon Drug Forecast by Application

12 Key Players Analysis

12.1 Novo Nordisk

12.1.1 Novo Nordisk Company Information

12.1.2 Novo Nordisk Glucagon Drug Product Offered

12.1.3 Novo Nordisk Glucagon Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Novo Nordisk Main Business Overview

12.1.5 Novo Nordisk Latest Developments

12.2 Eli Lilly

12.2.1 Eli Lilly Company Information

12.2.2 Eli Lilly Glucagon Drug Product Offered

12.2.3 Eli Lilly Glucagon Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Eli Lilly Main Business Overview

12.2.5 Eli Lilly Latest Developments

12.3 Fresenius Kabi

12.3.1 Fresenius Kabi Company Information

12.3.2 Fresenius Kabi Glucagon Drug Product Offered

12.3.3 Fresenius Kabi Glucagon Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Fresenius Kabi Main Business Overview

12.3.5 Fresenius Kabi Latest Developments

12.4 Torrent Labs

12.4.1 Torrent Labs Company Information

12.4.2 Torrent Labs Glucagon Drug Product Offered

12.4.3 Torrent Labs Glucagon Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Torrent Labs Main Business Overview

12.4.5 Torrent Labs Latest Developments

...

13 Research Findings and Conclusion

Table 1. Glucagon Drug Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Inject Glucagon

Table 3. Major Players of Nasal Glucagon

Table 4. Global Glucagon Drug Sales by Type (2016-2021) & (K Units)

Table 5. Global Glucagon Drug Sales Market Share by Type (2016-2021)

Table 6. Global Glucagon Drug Revenue by Type (2016-2021) & ($ million)

Table 7. Global Glucagon Drug Revenue Market Share by Type (2016-2021)

Table 8. Global Glucagon Drug Sale Price by Type (2016-2021)

Table 9. Global Glucagon Drug Sales by Application (2016-2021) & (K Units)

Table 10. Global Glucagon Drug Sales Market Share by Application (2016-2021)

Table 11. Global Glucagon Drug Value by Application (2016-2021)

Table 12. Global Glucagon Drug Revenue Market Share by Application (2016-2021)

Table 13. Global Glucagon Drug Sale Price by Application (2016-2021)

Table 14. Global Glucagon Drug Sales by Company (2019-2021) & (K Units)

Table 15. Global Glucagon Drug Sales Market Share by Company (2019-2021)

Table 16. Global Glucagon Drug Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Glucagon Drug Revenue Market Share by Company (2019-2021)

Table 18. Global Glucagon Drug Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Glucagon Drug Producing Area Distribution and Sales Area

Table 20. Players Glucagon Drug Products Offered

Table 21. Glucagon Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Glucagon Drug Sales by Region (2016-2021) (K Units)

Table 25. Global Glucagon Drug Sales Market Share by Region (2016-2021)

Table 26. Global Glucagon Drug Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Glucagon Drug Revenue Market Share by Region (2016-2021)

Table 28. Americas Glucagon Drug Sales by Country (2016-2021) & (K Units)

Table 29. Americas Glucagon Drug Sales Market Share by Country (2016-2021)

Table 30. Americas Glucagon Drug Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Glucagon Drug Revenue Market Share by Country (2016-2021)

Table 32. Americas Glucagon Drug Sales by Type (2016-2021) & (K Units)

Table 33. Americas Glucagon Drug Sales Market Share by Type (2016-2021)

Table 34. Americas Glucagon Drug Sales by Application (2016-2021) & (K Units)

Table 35. Americas Glucagon Drug Sales Market Share by Application (2016-2021)

Table 36. APAC Glucagon Drug Sales by Region (2016-2021) & (K Units)

Table 37. APAC Glucagon Drug Sales Market Share by Region (2016-2021)

Table 38. APAC Glucagon Drug Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Glucagon Drug Revenue Market Share by Region (2016-2021)

Table 40. APAC Glucagon Drug Sales by Type (2016-2021) & (K Units)

Table 41. APAC Glucagon Drug Sales Market Share by Type (2016-2021)

Table 42. APAC Glucagon Drug Sales by Application (2016-2021) & (K Units)

Table 43. APAC Glucagon Drug Sales Market Share by Application (2016-2021)

Table 44. Europe Glucagon Drug Sales by Country (2016-2021) & (K Units)

Table 45. Europe Glucagon Drug Sales Market Share by Country (2016-2021)

Table 46. Europe Glucagon Drug Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Glucagon Drug Revenue Market Share by Country (2016-2021)

Table 48. Europe Glucagon Drug Sales by Type (2016-2021) & (K Units)

Table 49. Europe Glucagon Drug Sales Market Share by Type (2016-2021)

Table 50. Europe Glucagon Drug Sales by Application (2016-2021) & (K Units)

Table 51. Europe Glucagon Drug Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Glucagon Drug Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Glucagon Drug Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Glucagon Drug Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Glucagon Drug Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Glucagon Drug Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Glucagon Drug Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Glucagon Drug Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Glucagon Drug Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Glucagon Drug

Table 61. Key Application and Potential Industries of Glucagon Drug

Table 62. Key Challenges of Glucagon Drug

Table 63. Key Trends of Glucagon Drug

Table 64. Glucagon Drug Distributors List

Table 65. Glucagon Drug Customer List

Table 66. Global Glucagon Drug Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Glucagon Drug Consumption Market Forecast by Region

Table 68. Global Glucagon Drug Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Glucagon Drug Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Glucagon Drug Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Glucagon Drug Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Glucagon Drug Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Glucagon Drug Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Glucagon Drug Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Glucagon Drug Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Glucagon Drug Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Glucagon Drug Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Glucagon Drug Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Glucagon Drug Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Glucagon Drug Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Glucagon Drug Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Glucagon Drug Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Glucagon Drug Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Glucagon Drug Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Glucagon Drug Revenue Market Share Forecast by Application (2021-2026)

Table 86. Novo Nordisk Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors

Table 87. Novo Nordisk Glucagon Drug Product Offered

Table 88. Novo Nordisk Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Novo Nordisk Main Business

Table 90. Novo Nordisk Latest Developments

Table 91. Eli Lilly Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors

Table 92. Eli Lilly Glucagon Drug Product Offered

Table 93. Eli Lilly Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Eli Lilly Main Business

Table 95. Eli Lilly Latest Developments

Table 96. Fresenius Kabi Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors

Table 97. Fresenius Kabi Glucagon Drug Product Offered

Table 98. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. Fresenius Kabi Main Business

Table 100. Fresenius Kabi Latest Developments

Table 101. Torrent Labs Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors

Table 102. Torrent Labs Glucagon Drug Product Offered

Table 103. Torrent Labs Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. Torrent Labs Main Business

Table 105. Torrent Labs Latest Developments

List of Figures

Figure 1. Picture of Glucagon Drug

Figure 2. Glucagon Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Glucagon Drug Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Glucagon Drug Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Glucagon Drug Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Inject Glucagon

Figure 10. Product Picture of Nasal Glucagon

Figure 11. Global Glucagon Drug Sales Market Share by Type in 2020

Figure 12. Global Glucagon Drug Revenue Market Share by Type (2016-2021)

Figure 13. Glucagon Drug Consumed in Emergency Kits

Figure 14. Global Glucagon Drug Market: Emergency Kits (2016-2021) & (K Units)

Figure 15. Glucagon Drug Consumed in General Use

Figure 16. Global Glucagon Drug Market: General Use (2016-2021) & (K Units)

Figure 17. Glucagon Drug Consumed in Diagnostic & Motility

Figure 18. Global Glucagon Drug Market: Diagnostic & Motility (2016-2021) & (K Units)

Figure 19. Glucagon Drug Consumed in Cardiogenic Shock

Figure 20. Global Glucagon Drug Market: Cardiogenic Shock (2016-2021) & (K Units)

Figure 21. Glucagon Drug Consumed in Others

Figure 22. Global Glucagon Drug Market: Others (2016-2021) & (K Units)

Figure 23. Global Glucagon Drug Sales Market Share by Application (2016-2021)

Figure 24. Global Glucagon Drug Revenue Market Share by Application in 2020

Figure 25. Glucagon Drug Revenue Market by Company in 2020 ($ Million)

Figure 26. Global Glucagon Drug Revenue Market Share by Company in 2020

Figure 27. Global Glucagon Drug Sales Market Share by Regions (2016-2021)

Figure 28. Global Glucagon Drug Revenue Market Share by Region in 2020

Figure 29. Americas Glucagon Drug Sales 2016-2021 (K Units)

Figure 30. Americas Glucagon Drug Revenue 2016-2021 ($ Millions)

Figure 31. APAC Glucagon Drug Sales 2016-2021 (K Units)

Figure 32. APAC Glucagon Drug Revenue 2016-2021 ($ Millions)

Figure 33. Europe Glucagon Drug Sales 2016-2021 (K Units)

Figure 34. Europe Glucagon Drug Revenue 2016-2021 ($ Millions)

Figure 35. Middle East & Africa Glucagon Drug Sales 2016-2021 (K Units)

Figure 36. Middle East & Africa Glucagon Drug Revenue 2016-2021 ($ Millions)

Figure 37. Americas Glucagon Drug Sales Market Share by Country in 2020

Figure 38. Americas Glucagon Drug Revenue Market Share by Country in 2020

Figure 39. Americas Glucagon Drug Sales Market Share by Type in 2020

Figure 40. Americas Glucagon Drug Sales Market Share by Application in 2020

Figure 41. United States Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 42. Canada Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 43. Mexico Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 44. Brazil Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 45. APAC Glucagon Drug Sales Market Share by Region in 2020

Figure 46. APAC Glucagon Drug Revenue Market Share by Regions in 2020

Figure 47. APAC Glucagon Drug Sales Market Share by Type in 2020

Figure 48. APAC Glucagon Drug Sales Market Share by Application in 2020

Figure 49. China Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 50. Japan Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 51. Korea Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 52. Southeast Asia Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 53. India Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 54. Australia Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 55. Europe Glucagon Drug Sales Market Share by Country in 2020

Figure 56. Europe Glucagon Drug Revenue Market Share by Country in 2020

Figure 57. Europe Glucagon Drug Sales Market Share by Type in 2020

Figure 58. Europe Glucagon Drug Sales Market Share by Application in 2020

Figure 59. Germany Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 60. France Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 61. UK Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 62. Italy Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 63. Russia Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 64. Middle East & Africa Glucagon Drug Sales Market Share by Country in 2020

Figure 65. Middle East & Africa Glucagon Drug Revenue Market Share by Country in 2020

Figure 66. Middle East & Africa Glucagon Drug Sales Market Share by Type in 2020

Figure 67. Middle East & Africa Glucagon Drug Sales Market Share by Application in 2020

Figure 68. Egypt Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 69. South Africa Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 70. Israel Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 71. Turkey Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 72. GCC Country Glucagon Drug Revenue Growth 2016-2021 ($ Millions)

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles